Another study indicated that after treatment with the nanoformulated LPO and LF on chitosan NPs, there was a considerable suppressed various pro-inflammatory markers, including TNF-α, IL-6, VEGF, and NF-κB in the treated breast MCF-7 and MDA cancer cells. This evidence concerns the gene NFKB1 and cancer.